![Stephen Keith Rhind](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Keith Rhind
Direttore/Membro del Consiglio presso Quell Therapeutics Ltd.
Posizioni attive di Stephen Keith Rhind
Società | Posizione | Inizio | Fine |
---|---|---|---|
Quell Therapeutics Ltd.
![]() Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Stephen Keith Rhind
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Quell Therapeutics Ltd.
![]() Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Stephen Keith Rhind
- Esperienza